‌

US Patent 11565107 Tolerable and minimally invasive skin electroporation device

Patent 11565107 was granted and assigned to Inovio Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

Inovio Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

January 31, 2023

0

Patent Application Number

135817020

Date Filed

March 1, 2011

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

A novel electroporation device for the delivery of vaccines that is both effective in generating a protective immune response and tolerable delivery to a subject (or near painless); and also methods of using same device to vaccinate a subject against a variety of infectious diseases and types of cancer in a near painless.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11565107 Tolerable and minimally invasive skin electroporation device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.